发明名称 Detecting an embryonic cell surface marker e.g. cartilage-derived morphogenic protein CDMP-1 so as to positively identify viable precursor cells that have entered a post-natal differentiation pathway
摘要 <p>Positively identifying viable precursor cells that have entered a post-natal differentiation pathway comprises using reagents, ligands and/or antibodies to recognize an embryonic cell surface marker such as an expressed morphogenic protein, its homolog or a marker co-expressed and/or co-detectable with this marker, so as to sort and enrich the precursor cells. Independent claims are also included for: (1) producing or repairing connective tissue in a mammal by using skeletal precursor cells (I), marked with an expressed morphogenic protein, its homologs or co-expressed and/or co-detectable markers e.g. FGFR3 (fibroblast growth factor receptor 3), a gene, protein or mRNA expressed in the precursor cells; (2) using (I) as a source of growth factors; (3) a culture of viable precursor cells (II) that have entered a specific post-natal differentiation pathway and which express an embryonic marker which is an expressed morphogenic protein, its homolog or a marker co-expressed and/or co-detectable with this marker; (4) an implant (III) comprising (II), especially skeletal precursor cells; and (5) a diagnostic for identifying a positive marker of (II).</p>
申请公布号 DE20023640(U1) 申请公布日期 2005.06.23
申请号 DE2000223640U 申请日期 2000.10.06
申请人 TIGENIX N.V., LEUVEN 发明人
分类号 A61K9/00;A61K35/12;A61L27/22;A61L27/38;A61P19/02;A61P19/04;C12N5/077;G01N33/53;(IPC1-7):C12N5/08;A61K38/18 主分类号 A61K9/00
代理机构 代理人
主权项
地址